Azelastine Hydrochloride Spray, Metered
Product Images NDC 71205-449

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 71205-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figurea.jpg (Figurea)

FDA Label Image

Figureb.jpg (Figureb)

FDA Label Image

Figurec.jpg (Figurec)

FDA Label Image

Figured.jpg (Figured)

FDA Label Image

Figuree.jpg (Figuree)

FDA Label Image

Figuref-and-g.jpg (Figuref And G)

FDA Label Image

71205-449-30 (Lbl30ml)

71205-449-30 (Lbl30ml)
This is a description of a medication called Azelastine HCI 0.1%, which is a nasal solution used for intranasal administration only. Each mL of the solution contains 1 mg of Azelastine hydrochloride. It is for RX only and users should avoid spraying it in their eyes. The medication should be stored upright at 20°-25°C (68°-77°F) and kept away from children. The manufacturer is Apotex Inc. from Toronto, Ontario, Canada. The package insert should also be referred to for further information.*
FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.